2m 2m 2m 2m 2m 2m 2m
Aclaris Therap (ACRS)
NASDAQ
$6.40-$0.010 (-0.16%)
Price as of Aug 21, 2026 7:50 PM EDT- $943.5MMarket Cap
- 256.11%1-Year Change
- BiotechnologyIndustry
Aclaris Therap (ACRS)
$6.40-$0.010 (-0.16%)
ACRS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $6.41 | ||
Change | +$0.08 (+1.26%) | ||
Open | $6.36 | ||
High | $6.50 | ||
Low | $6.29 | ||
Previous Close | $6.33 | ||
Volume | 2,208,483 | ||
30-Day Average Volume | 1,891,941 | ||
1-Week Change | 10.90% | ||
1-Month Change | 12.65% | ||
1-Year Change | 256.11% | ||
3-Year Change | -12.67% | ||
5-Year Change | -53.48% | ||
Fundamentals | |||
Shares Outstanding | 147.2M | ||
Total Assets | $179.7M | ||
Market Cap | $943.5M | ||
Enterprise Value | $924.4M | ||
Period: QTR TTM FY | |||
Revenue | $356,000.00 | ||
Net Income | -$21.5M | ||
Free Cash Flow | -$19.9M | ||
EBIT | -$21.5M | ||
EBITDA | -$21.4M | ||
Net Working Capital | $69.5M | ||
EPS | -$0.15 | ||
Enterprise Value/EBITDA | -43 | ||
Enterprise Value/Revenue | 2,597 | ||
P/B | 8 | ||
P/E | -43 | ||
PEG | N/A | ||
Price/Free Cash Flow | -47 | ||
Price/Operating Cash Flow | -48 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue